日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: PPARδ binding to heme oxygenase 1 promoter prevents angiotensin II-induced adipocyte dysfunction in Goldblatt hypertensive rats

撤稿声明:PPARδ与血红素加氧酶1启动子的结合可预防Goldblatt高血压大鼠中血管紧张素II诱导的脂肪细胞功能障碍

Sodhi, K; Puri, N; Kim, D H; Hinds, T D; Stechschulte, L A; Favero, G; Rodella, L; Shapiro, J I; Jude, D; Abraham, N G

Protein phosphatase PP5 controls bone mass and the negative effects of rosiglitazone on bone through reciprocal regulation of PPARγ (peroxisome proliferator-activated receptor γ) and RUNX2 (runt-related transcription factor 2)

蛋白磷酸酶 PP5 通过对 PPARγ(过氧化物酶体增殖激活受体 γ)和 RUNX2(Runt 相关转录因子 2)的相互调节来控制骨量和罗格列酮对骨骼的负面影响。

Stechschulte, Lance A; Ge, Chunxi; Hinds, Terry D Jr; Sanchez, Edwin R; Franceschi, Renny T; Lecka-Czernik, Beata

Deletion of the glucocorticoid receptor chaperone FKBP51 prevents glucocorticoid-induced skin atrophy

删除糖皮质激素受体伴侣 FKBP51 可预防糖皮质激素引起的皮肤萎缩

Gleb Baida, Pankaj Bhalla, Alexander Yemelyanov, Lance A Stechschulte, Weinian Shou, Ben Readhead, Joel T Dudley, Edwin R Sánchez, Irina Budunova

Marrow Adipose Tissue: Skeletal Location, Sexual Dimorphism, and Response to Sex Steroid Deficiency

骨髓脂肪组织:骨骼位置、性别二态性及对性激素缺乏的反应

Lecka-Czernik, Beata; Stechschulte, Lance A; Czernik, Piotr J; Sherman, Shermel B; Huang, Shilong; Krings, Amrei

PPARG Post-translational Modifications Regulate Bone Formation and Bone Resorption

PPARG的翻译后修饰调控骨形成和骨吸收

Stechschulte, L A; Czernik, P J; Rotter, Z C; Tausif, F N; Corzo, C A; Marciano, D P; Asteian, A; Zheng, J; Bruning, J B; Kamenecka, T M; Rosen, C J; Griffin, P R; Lecka-Czernik, B

Glucocorticoid Receptor β Induces Hepatic Steatosis by Augmenting Inflammation and Inhibition of the Peroxisome Proliferator-activated Receptor (PPAR) α

糖皮质激素受体 β 通过增强炎症和抑制过氧化物酶体增殖激活受体 (PPAR) α 诱导肝脂肪变性

Joseph S Marino, Lance A Stechschulte, David E Stec, Andrea Nestor-Kalinoski, Sydni Coleman, Terry D Hinds Jr

Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2)

蛋白磷酸酶PP5通过相互调节PPARγ(过氧化物酶体增殖激活受体γ)和RUNX2(Runt相关转录因子2)来控制骨量和罗格列酮对骨骼的负面影响

Lance A Stechschulte, Chunxi Ge, Terry D Hinds Jr, Edwin R Sanchez, Renny T Franceschi, Beata Lecka-Czernik

FKBP51 Null Mice Are Resistant to Diet-Induced Obesity and the PPARγ Agonist Rosiglitazone

FKBP51 基因敲除小鼠对饮食引起的肥胖和 PPARγ 激动剂罗格列酮具有抵抗力

Lance A Stechschulte, Bin Qiu, Manya Warrier, Terry D Hinds Jr, Man Zhang, Hao Gu, Yuxue Xu, Saja S Khuder, Lucia Russo, Sonia M Najjar, Beata Lecka-Czernik, Weidong Yong, Edwin R Sanchez

Glucocorticoid receptor β stimulates Akt1 growth pathway by attenuation of PTEN

糖皮质激素受体 β 通过减弱 PTEN 来刺激 Akt1 生长通路

Lance A Stechschulte, Leah Wuescher, Joseph S Marino, Jennifer W Hill, Charis Eng, Terry D Hinds Jr

Partial agonist, telmisartan, maintains PPARγ serine 112 phosphorylation, and does not affect osteoblast differentiation and bone mass

部分激动剂替米沙坦维持 PPARγ 丝氨酸 112 磷酸化,并且不影响成骨细胞分化和骨量

Vipula Kolli, Lance A Stechschulte, Abigail R Dowling, Sima Rahman, Piotr J Czernik, Beata Lecka-Czernik